First report of safety, PK, and preliminary antitumor activity of the oral EGFR/HER2 exon 20 inhibitor TAK-788 (AP32788) in non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Doebele, R. C.; Riely, G. J.; Spira, A. I.; Horn, L.; Piotrowska, Z.; Costa, D. B.; Neal, J. W.; Zhang, S.; Reichmann, W.; Kerstein, D.; Li, S.; Janne, P. A. |
| Abstract Title: | First report of safety, PK, and preliminary antitumor activity of the oral EGFR/HER2 exon 20 inhibitor TAK-788 (AP32788) in non-small cell lung cancer (NSCLC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 463s |
| Language: | English |
| ACCESSION: | WOS:000442916003189 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9015 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9015 -- Source: Wos |
